Ziad Mallat Selected Research

Secretory Phospholipases A2

11/2021	Association between serum secretory phospholipase A2 and risk of ischaemic stroke.
3/2019	Tracking of secretory phospholipase A2 enzyme activity levels from childhood to adulthood: a 21-year cohort.
10/2015	Periodontal microbiota and phospholipases: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).
4/2015	PLA2G10 Gene Variants, sPLA2 Activity, and Coronary Heart Disease Risk.
5/2014	[Lp-PLA2 and sPLA2: cardiovascular biomarkers].
4/2014	Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary heart disease: modified Mendelian randomization analysis using PLA2G5 expression levels.
11/2013	Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study.
3/2013	Group X secreted phospholipase A2 limits the development of atherosclerosis in LDL receptor-null mice.
12/2012	Circulating levels of secretory- and lipoprotein-associated phospholipase A2 activities: relation to atherosclerotic plaques and future all-cause mortality.
2/2012	Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ziad Mallat Research Topics

Disease

90	Atherosclerosis 11/2021 - 05/2002
33	Inflammation (Inflammations) 04/2021 - 10/2003
20	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2007
16	Myocardial Infarction 11/2021 - 10/2005
16	Atherosclerotic Plaque (Atheroma) 01/2021 - 10/2002
13	Rupture 01/2021 - 03/2003
11	Aneurysm (Aneurysms) 01/2022 - 02/2010
11	Abdominal Aortic Aneurysm 01/2021 - 06/2011
9	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 10/2005
7	Acute Coronary Syndrome 01/2021 - 10/2005
6	Thrombosis (Thrombus) 01/2019 - 03/2003
5	Infarction (Infarctions) 01/2021 - 03/2013
5	Heart Failure 12/2020 - 11/2004
5	Coronary Disease (Coronary Heart Disease) 11/2018 - 11/2009
4	Infections 11/2019 - 10/2007
4	Aortic Rupture 01/2019 - 12/2011
4	Aortic Aneurysm (Aneurysm, Aortic) 01/2019 - 02/2010
4	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 10/2010
4	Ischemia 10/2009 - 09/2002
3	Disease Progression 01/2022 - 09/2015
3	Aortic Dissection 10/2018 - 01/2016
3	Hypercholesterolemia 07/2017 - 04/2008
3	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 06/2002
3	Stroke (Strokes) 09/2011 - 02/2006
2	Ischemic Stroke 11/2021 - 10/2018
2	Ventricular Remodeling 01/2021 - 01/2018
2	Necrosis 12/2020 - 10/2018
2	Hypertension (High Blood Pressure) 10/2018 - 01/2017
2	Obesity 10/2018 - 01/2018
2	Metabolic Diseases (Metabolic Disease) 01/2018 - 01/2015
2	Reperfusion Injury 01/2018 - 11/2004
2	Heart Diseases (Heart Disease) 01/2018 - 10/2007
2	Insulin Resistance 01/2018 - 01/2009
2	Neoplasms (Cancer) 01/2018 - 12/2014
2	Vascular Diseases (Vascular Disease) 10/2015 - 12/2014
2	Body Weight (Weight, Body) 08/2015 - 10/2003

Drug/Important Bio-Agent (IBA)

17	Secretory Phospholipases A2IBA 11/2021 - 10/2005
17	Apolipoproteins E (ApoE)IBA 01/2020 - 02/2003
15	CytokinesIBA 12/2020 - 10/2002
14	CholesterolIBA 01/2021 - 05/2002
13	LDL Receptors (LDL Receptor)IBA 01/2021 - 08/2004
12	ApolipoproteinsIBA 01/2020 - 09/2003
10	Angiotensin IIIBA 01/2022 - 02/2010
10	Interleukin-10 (Interleukin 10)IBA 01/2019 - 08/2004
10	CollagenIBA 07/2017 - 10/2002
9	Lipoproteins (Lipoprotein)IBA 01/2019 - 10/2010
8	Biomarkers (Surrogate Marker)IBA 04/2021 - 04/2006
8	EnzymesIBA 03/2019 - 02/2012
8	LipidsIBA 01/2018 - 02/2006
8	Phospholipases (Phospholipase)IBA 10/2015 - 11/2010
7	AntibodiesIBA 11/2021 - 06/2011
7	InterleukinsIBA 12/2020 - 08/2008
7	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 10/2002
7	oxidized low density lipoproteinIBA 01/2017 - 04/2007
7	Interleukin-17 (Interleukin 17)IBA 02/2015 - 09/2009
5	LigandsIBA 12/2020 - 12/2002
5	Immunoglobulin M (IgM)IBA 01/2019 - 10/2011
5	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 05/2014 - 09/2011
5	Transforming Growth Factor beta (TGF-beta)IBA 12/2013 - 10/2002
4	AntigensIBA 11/2019 - 02/2006
4	InflammasomesIBA 01/2019 - 04/2014
4	Peptides (Polypeptides)IBA 12/2016 - 06/2002
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016 - 09/2002
4	C-Reactive ProteinIBA 12/2012 - 08/2008
3	Interleukin-2 (IL2)IBA 01/2021 - 01/2018
3	Phosphotransferases (Kinase)IBA 01/2021 - 01/2015
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 12/2012
3	Interleukin-33IBA 12/2020 - 10/2018
3	MicroRNAs (MicroRNA)IBA 07/2019 - 01/2014
3	Immunoglobulin G (IgG)IBA 01/2019 - 10/2011
3	Pancreatic Elastase (Elastase)IBA 01/2019 - 09/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 08/2015
3	Metalloproteases (Metalloproteinases)IBA 01/2018 - 08/2008
3	Monoclonal AntibodiesIBA 11/2017 - 08/2010
3	Biological ProductsIBA 10/2016 - 11/2010
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2016 - 08/2008
3	Proteins (Proteins, Gene)FDA Link 01/2016 - 11/2004
3	Interleukin-18 (Interleukin 18)IBA 08/2015 - 09/2002
3	Messenger RNA (mRNA)IBA 04/2014 - 11/2004
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2013 - 10/2002
3	ChemokinesIBA 05/2011 - 01/2005
2	KynurenineIBA 01/2021 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 11/2020 - 12/2012
2	EpitopesIBA 01/2019 - 12/2007
2	B-Cell Activating FactorIBA 11/2018 - 07/2012
2	B-Cell Activation Factor ReceptorIBA 11/2018 - 07/2012
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 01/2018
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2018 - 09/2015
2	Interleukin-22 (IL-22)IBA 01/2018 - 01/2018
2	Troponin T (Troponin T1)IBA 01/2018 - 09/2011
2	Tissue Inhibitor of Metalloproteinase-1IBA 09/2017 - 08/2008
2	Immunoglobulin E (IgE)IBA 07/2017 - 01/2017
2	c-Mer Tyrosine KinaseIBA 03/2016 - 08/2008
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2016 - 08/2008
2	Therapeutic UsesIBA 04/2015 - 02/2010

Therapy/Procedure

13	Therapeutics 01/2022 - 12/2003
4	Ligation 01/2018 - 12/2003
3	Immunomodulation 01/2020 - 09/2004
3	Immunotherapy 11/2018 - 01/2016
2	Injections 01/2020 - 03/2013